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Abstract Metallothionein-3 (MT-3) is a brain-speci¢c MT,
which is downregulated in Alzheimer’s disease. The N-terminal
region of CdMT-3 is highly dynamic and has escaped structural
characterization by nuclear magnetic resonance. We have used
electrospray ionization mass spectrometry to probe conforma-
tional states of cadmium- and zinc-substituted metalloforms of
MT-3 and can demonstrate that the N-terminal L-domain of
MT-3 ¢lled with Cd2+ has a more open conformation than
that ¢lled with Zn2+. The results suggest that the larger Cd2+
ions cannot isostructurally replace zinc in the L-domain of MT-
3 whereas in the case of MT-1 and MT-2 the replacement is
isostructural. Speci¢c metal binding properties of the L-domain
of MT-3 may be essential for ful¢lling the speci¢c role of MT-3
in the brain. * 2002 Published by Elsevier Science B.V. on
behalf of the Federation of European Biochemical Societies.
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1. Introduction
Metallothioneins (MTs) constitute a class of small cysteine-
rich proteins adapted for the binding of essential (Zn2þ and
Cuþ) and toxic (Cd2þ, Hg2þ) transition metals [1]. Mamma-
lian MTs contain 60^68 amino acid residues with an abso-
lutely conserved pattern of 20 Cys residues. MTs are poly-
morphous proteins and the known mammalian MT isoforms
are grouped into four classes: MT-1, MT-2, MT-3 and MT-4,
according to the total charge and length of the polypeptide
chain [2]. MT-1 and MT-2 are expressed in almost all tissues
[3], whereas expression of MT-3 and MT-4 is cell-speci¢c, and
is regulated by di¡erent mechanisms [4,5]. MT-3 (also known
as growth inhibitory factor), is a brain-speci¢c MT, which in
contrast to common MTs inhibits the growth of cultured neu-
rons and is downregulated in Alzheimer’s disease [6,7]. Evi-
dently, MT-3 ful¢ls biological roles distinct from those of
MT-1/2, which should rely on a di¡erent structure and/or
chemical properties (binding of metals, reactivity towards ox-
idants and other electrophiles, etc.) of MT-3.
The structure of MTs has been extensively studied by multi-
nuclear nuclear magnetic resonance (NMR) [8] and by X-ray
crystallography [9]. In these studies 113Cd-NMR has proven
to be indispensable and a powerful tool in the elucidation of
the correct 3D structure of mammalian MT-1 and MT-2
[8,10]. In all resolved structures mammalian MTs bind seven
divalent metals (zinc and/or cadmium) and the protein ex-
poses two domains, both folded into compact metal^thiolate
clusters. The N-terminal L-domain (amino acid residues 1^31)
contains a cluster of three metals coordinated with nine thio-
lates and the C-terminal K-domain contains a cluster of four
metals coordinated with 11 thiolates [10]. In the case of the
common MTs, the overall fold of zinc- and cadmium-substi-
tuted metalloforms is practically identical [11] which con¢rms
that cadmium replaces zinc isostructurally in the case of com-
mon MTs.
MT-3 consists of 68 amino acid residues and has two inserts
^ a single amino acid insert (Thr) in the N-terminal region and
a hexapeptide glutamate-rich insert in the C-terminal region
of the protein [6]. Although MT-3 has approximately 70%
identity with other MT sequences, it has escaped full struc-
tural characterization so far [12^14]. The structural studies of
CdMT-3 by NMR have resolved only the structure of the
C-terminal half of MT-3, which is folded into a four-metal
cluster similar to that of other MTs [12]. The N-terminal
region of CdMT-3 exposes enhanced conformational dynam-
ics and has structurally not been characterized so far. The
dynamic phenomena observed in CdMT-3 are commonly ex-
plained by the conformational dynamics in the N-terminal
Cd3S9 cluster of Cd7MT-3 [12^14]. We have recently demon-
strated by electrospray ionization mass spectrometry (ESI
MS) that MT-3 binds metals non-cooperatively and exists in
solution as a dynamic mixture of multiple metalloforms,
which could be an additional reason behind the unusual be-
havior of CdMT-3 in NMR studies [15]. We have also noticed
that CdMT-3 is more heterogeneous than ZnMT-3. There-
fore, it is not excluded that the conformational state of
CdMT-3 is di¡erent from that of ZnMT-3.
In the present work, we have used ESI MS for conforma-
tional analysis of Cd- and Zn-substituted metalloforms of
MT-3 and can demonstrate that Cd-substituted metalloforms
of MT-3 have more open conformations in solution than Zn-
substituted metalloforms, which complicates application of
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CdMT-3 for structural studies, but gives additional evidence
for speci¢c metal binding properties of MT-3.
2. Materials and methods
2.1. Isolation of MT-1 and MT-3
Rabbit MT-1 was isolated from livers of cadmium-exposed rabbits
and the apoMT-1A form was puri¢ed to homogeneity by reverse
phase HPLC as described [15]. Recombinant human MT-3 was ex-
pressed in Escherichia coli and the apoMT-3 form was puri¢ed by
reverse phase HPLC [15]. Lyophilized apoMT-1A and apoMT-3
were used for reconstitution experiments.
2.2. Reconstitution of MT metalloforms
MT-3 was reconstituted by addition of various concentrations of
metals (Cd2þ acetate or Zn2þ acetate) to apoMT-3 (20 WM), in de-
gassed 5 mM ammonium acetate bu¡er, pH 7.5, containing 25 WM
1,4-dithiothreitol (DTT). Samples were injected into the mass spec-
trometer using a syringe pump. MT-1A was reconstituted by addition
of metal salts (Cd2þ acetate or Zn2þ acetate) to apoMT-1A (10 WM)
in degassed 20 mM formic acid, pH 2.7, containing 25 WM DTT, and
pH of the solution was raised to pH 8.5 with ammonia solution.
Before MS analysis, the bu¡er was exchanged to 5 mM ammonium
acetate, pH 7.5, using MicroSpin1 G-25 columns and the eluate was
injected into the MS instrument using a syringe pump. MS spectra
were recorded on an Ettan1 electrospray time-of-£ight mass spec-
trometer (ESI TOF MS, Amersham Biosciences, Uppsala, Sweden).
3. Results and discussion
3.1. Reconstitution of MT-3 with Zn2+ and Cd2+ ions
MS spectra of MT-3 reconstituted with increasing stoichio-
metries of Zn2þ ions are presented in Fig. 1. At stoichiome-
tries of added zinc up to 7, metalloforms of MT-3 expose
mainly the charge state +5 and only at higher stoichiometries
of bound metals (8^10), the proportion of charge state +6
increases in the MS spectra.
MS spectra of MT-3 reconstituted with increasing stoichi-
ometries of Cd2þ ions are presented in Fig. 2. All CdMT-3
metalloforms display proportionally more ions in the charge
state +6 than the corresponding ZnMT-3 metalloforms. How-
Fig. 1. ESI TOF spectra of MT-3 (10 WM) reconstituted with di¡erent concentrations of Zn2þ in 5 mM ammonium acetate, pH 7.5, containing
25 WM DTT, 25‡C. Numbers on the peaks denote the metal stoichiometry of the complex.
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ever, in the case of CdMT-3 there is a continuous increase of
the population of +6 ions in the MS spectra in parallel with
an increasing metal stoichiometry of metalloforms.
ESI MS spectra of Zn7MT-1 and Cd7MT-1 are presented in
Fig. 3. Both metalloforms display in a similar manner a main
fraction of +5 ions and minor fraction of +6 ions in the
spectra.
3.2. Application of charge state distribution analysis for
probing protein conformations
ESI MS has developed into a powerful technique, which
could, besides mass determination, be applied also for probing
conformation and dynamics of proteins under a variety of
conditions. The latter approach is based on the assumption
that in the process of electrospray ionization compact protein
conformations produce lower charge state ions than more
open conformations, which is most probably caused by en-
hanced electrostatic repulsion of charges [16]. A number of
studies with well-studied model proteins have demonstrated
that the assumption above is valid and charge state distribu-
tion analysis can be e¡ectively used for analysis of protein
conformations [17,18].
In the present work, we have used ESI MS for comparison
of conformational states of Cd- and Zn-substituted metallo-
forms of MT-3. The results demonstrate that Zn- and CdMT-
3 forms di¡er substantially in their charge state distribution in
ESI MS spectra (Fig. 4). Generally, all CdMT-3 metalloforms
display proportionally more ions in the higher charge state
(+6) than in the lower charge state (+5), which is not the
case for the corresponding ZnMT-3 forms. In the case of
ZnMT-3 the charge state distribution is similar for all metal-
loforms with metal stoichiometry up to 7, and starts to in-
crease in favor of the higher charge state (+6) at higher metal
stoichiometries. This result indicates that the conformation of
ZnMT-3 is compact up to metal stoichiometry 7, and opens
up at elevated metal stoichiometries. Metalloforms of CdMT-
3 with a low metal stoichiometry (1^4) expose a slightly higher
proportion of charge state +6 than corresponding ZnMT-3
Fig. 2. ESI TOF spectra of MT-3 (10 WM) reconstituted with di¡erent concentrations of Cd2þ in 5 mM ammonium acetate, pH 7.5, containing
25 WM DTT, 25‡C. Numbers on the peaks denote the metal stoichiometry of the complex.
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metalloforms, which demonstrates that the four-metal cluster
of MT-3, which is ¢lled ¢rst [15], is slightly more open than
the four-metal cluster of ZnMT-3. However, metalloforms of
CdMT-3 with metal stoichiometries 5, 6, and 7 expose a suf-
¢ciently higher proportion of ions in charge state +6 than
corresponding ZnMT-3 forms, which demonstrates that
MT-3 forms with Cd2þ in the L-domain have signi¢cantly
more open conformations than Zn2þ-substituted forms.
Charge state distribution of MT-3 with Cd2þ stoichiometries
higher than 7 is even further shifted towards the charge state
+6 (Fig. 4). The results demonstrate that the L-cluster of
MT-3 cannot accommodate Cd2þ into an equally compact
structure as is the case for Zn2þ ions, and provide evidence
for a non-isostructural replacement of Zn2þ with Cd2þ ions in
the L-cluster of MT-3. The situation is speci¢c for MT-3, as
Zn7MT-1 and Cd7MT-1 display the same distribution of
charged states in MS spectra, which additionally con¢rms
that Zn7MT-1 and Cd7MT-1 have similar conformations in
solution [11]. As Cd2þ ions have very similar coordination
preferences and expose similar or higher chemical a⁄nities
towards di¡erent ligands as compared to Zn2þ, the observed
conformational di¡erences between Cd- and Zn-substituted
MT-3 could be reasonably explained only with the di¡erent
ionic radii of Cd2þ (0.97 AT ) and Zn2þ (0.71 AT ). It is feasible
that the L-cluster of MT-3, in contrast to common MTs, can-
not accommodate metals as large as Cd2þ into a compact
cluster structure. EXAFS studies of ZnMT-3 and its L-cluster
demonstrate that the Zn^Zn distance in the L-cluster of MT-3
is equal to 3.2 AT [19], which is unusually short as compared to
3.8 AT for the Zn^Zn distance in the structure of MT-2 [9].
Thus EXAFS data demonstrate that the L-cluster of MT-3 is
more compact than the L-cluster of common MTs, which
supports our conclusion that Cd2þ ions are size-excluded
from the L-cluster of MT-3. Our data present the ¢rst example
for non-isostructural replacement of Zn2þ with Cd2þ ions in
the case of MTs which complicates application of CdMT-3 for
structural studies as the more open conformation of Cd-sub-
stituted protein may cause higher heterogeneity of the CdMT-
3 sample as compared with ZnMT-3 [15] and lead to en-
hanced dynamics of CdMT-3 observed in NMR studies.
The presented results give additional evidence for speci¢c
metal binding properties of MT-3 as compared with common
MTs, which may be related to the speci¢c physiological func-
tion(s) of this particular MT isoform. MT-3 is speci¢cally
expressed in the brain and it is not involved in detoxi¢cation
of Cd2þ ions, which is one of the commonly accepted func-
tions of MT-1/MT-2 [3,20]. Therefore Cd2þ is a non-native
metal ion for MT-3 and it is not surprising that MT-3 is not
well accommodated for its binding. Although MT-3 isolated
from native tissues contains some amount of copper [21], the
native metal for MT-3 in the brain is most likely zinc. The
most evident con¢rmation for this conclusion has been ob-
tained from transgenic mouse experiments, where MT-3 over-
expression resulted in an increase of the zinc content in the
brain, but did not in£uence the copper content [22]. Previ-
Fig. 3. ESI TOF spectra of MT-1 (20 WM) reconstituted with Zn2þ and Cd2þ in 5 mM ammonium acetate, pH 7.5, containing 25 WM DTT,
25‡C. Numbers on the peaks denote the metal stoichiometry of the complex.
Fig. 4. Ratio of charge state +6 and charge state +5 ion intensities
in the ESI TOF MS spectra of Zn- and Cd-substituted metalloforms
of MT-3.
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ously we have proposed that the speci¢c metal binding prop-
erties of MT-3 may be e¡ectively used for bu¡ering of highly
£uctuating concentrations of zinc and transfer of zinc into
synaptic vesicles in zincergic neurons [15]. Speci¢c metal bind-
ing properties of the L-cluster of MT-3, demonstrated in the
present paper, may also support the functioning of MT-3 in
the brain; however, the mechanism(s) involved are currently
unknown. At the same time it is also not excluded that speci¢c
metal binding properties of MT-3 are connected with speci¢c
antioxidative properties of MT-3 [23,24], which are responsi-
ble for growth inhibitory activity of MT-3 towards cultured
neurons in vitro [23] but which may also have physiological
relevance [24].
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